DPP4 and diabetic kidney disease: Klein et al. [37] believe that urinary DPP-4 could potentially be used as a predictive biomarker of improved urine albumin-to-creatinine ratio (UACR) in response to linagliptin treatment in patients with diabetic kidney disease.